synthetic peptide comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-20. Numbers and descriptions here follow the published literature rather than marketing material.
AOD-9604 drew attention in the 1990s and 2000s as a potential anti-obesity agent. Early work explored both injectable and oral routes, which is unusual for a peptide of this size. Animal studies reported changes in fat metabolism without the growth-promoting or insulin-like effects associated with full-length growth hormone. Subsequent human trials produced mixed or modest results, and the compound did not obtain regulatory approval for weight management in major markets. It remains known mainly through research literature, sports anti-doping listings, and non-approved supplement advertising.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
The compound has been studied as a potential treatment for obesity and related metabolic conditions. Published trials have examined changes in body weight, fat mass, and safety markers over limited durations. Results have been mixed or modest, and no large-scale outcome trials are established. Regulatory agencies in several countries have not approved it as a therapeutic drug. Some commercial products have been marketed outside regulated pharmaceutical channels, which raises questions about quality and claims.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | Fragment analog of human growth hormone |
| Sequence basis | hGH 176–191 region | Modified C-terminal fragment |
| Common synonyms | AOD-9604; AOD9604; hGH fragment | Research and trade names vary |
| Regulatory status | Not approved as a drug | Prohibited in competitive sport |
| Research code | AOD9604 | Used in scientific and patent literature |
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.
Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.
AOD-9604 has been investigated mainly in the context of body fat and metabolic endpoints. Some early animal and small human studies reported changes in fat mass or lipid markers, but findings were not uniform. Larger, well-controlled trials that would establish efficacy are lacking in the public literature. As a result, claims about weight loss or metabolic benefit remain investigational rather than established. The distinction between a research finding and a proven clinical outcome is central to discussing this peptide.
== Research career and academic posts == After completing graduate school, Fenn's first job was with Monsanto, working in the Phosphate Division and producing polychlorinated biphenyls (PCBs). Fenn and his colleague James Mullen became disenchanted with the direction of work at Monsanto, and they resigned together in 1943. Fenn worked briefly at a small company named Sharples Chemicals that focused on the production of amyl chloride derivatives. In 1945, he joined Mullen at his new startup, Experiment, Inc, focusing on research and development. Fenn's first publication came in 1949 as a result of his work with Mullen. That this publication came ten years after he completed graduate school made Fenn somewhat of a rarity amongst academics. In 1952, Fenn moved to Princeton University as Director of Project SQUID, a program to support research related to jet propulsion that was funded by the Office of Naval Research. During this period, Fenn started his work developing supersonic atomic and molecular beam sources, which are now widely used in chemical physics research. After working with Project SQUID, Fenn returned to Yale University in 1967. He held a joint appointment in the chemistry and engineering departments until 1987, conducting much of his research in Mason Laboratory. In 1987, Fenn had reached Yale's mandatory retirement age. He became a professor emeritus, entitling him to office space at the university, but costing him most of his laboratory space and research assistants.
==== Chain stores ==== Chain stores did not become popular in the United States until the end of World War I. It was reported in 1929 that chain stores accounted for 39% of all grocery sales in the United States. Chain stores' success is related to their ability to undersell smaller distributors. An anti-chain movement arose in response to the success of the chain stores during the Great Depression, but caused little detriment to the success and profitability of the chains.
The attitude that Mexico takes in the present eventuality is based on the fact that our determination stems from a need for legitimate defense. We know the limits of our military resources and we know that, given the enormity of the international masses in conflict, our role in the current conflict will not consist of extra-continental war actions, for which we are not prepared. "Simulated neutrality" had been left behind and Mexico was explicitly on the side of the Allies as a belligerent country. Lázaro Cárdenas was appointed Secretary of Defense, the National Military Service (SMN) was created, the United States delivered armaments to improve the capacity of the Mexican army, and the properties of German, Japanese and Italian citizens were seized. Even so, Avila Camacho indicated that Mexico's role in the conflict was not on the battlefield, but to prepare his defenses and provide resources to its new allies. Between June and September 1942 the U-Boats sank four more ships: Tuxpam, Las Choapas, Oaxaca and Amatlán. In view of this situation, the United States, under the pretext of the possibility of aggression by Japan on the coasts of the Pacific Ocean, began discreet negotiations to be allowed to install a military base on the Baja California peninsula; according to historian Humberto Musacchio, that there was speculation that he might have tried to occupy that part of Mexican territory without success.
===== Liver ===== In 2022, researchers proposed a new method for printing vascularized human liver tissue. This new method consisted of using a 3D printer capable of holding seven different bioinks, with the ability to switch rapidly between these different bioinks to print different structures and shapes in the liver tissue. Due to the overall complexity of the organ, they were unable to print an entire liver but were still able to successfully print pieces of densely vascularized liver tissue.
Trails has been praised for its character arcs and worldbuilding, with its scope and sense of continuity being compared to the A Song of Ice and Fire novels by George R. R. Martin, the Forgotten Realms setting for Dungeons & Dragons, and the Marvel Cinematic Universe. Despite the series' English localization being praised for their quality, their slow release pace has been criticized, with them tending to lag years behind the original Japanese games. The music written for the series by Falcom Sound Team jdk, the company's team of composers, has also been praised. Characters or other elements from Trails have been featured in crossover promotions with other games, including Monster Hunter Frontier G, Chain Chronicle V, Dead or Alive 5, Fantasy Earth Zero, Langrisser Mobile, Utawarerumono: Zan, Valkyrie Anatomia, and a few Japanese mobile games. Characters from the series were also featured in a 2019 collaboration event with VREX, a virtual reality game arcade and café in Japan. As of 2021, a list of Trails characters was the largest article on the Japanese Wikipedia at over 440,000 characters. As of 2025, the series had sold nine million copies worldwide.
Sources: en.wikipedia.org
In baboon skeletal muscle, which consists of fully differentiated postmitotic cells, less than 3% of myonuclei contain damaged telomeres and this percentage does not increase with age. Thus, telomere shortening does not appear to be a major factor in the aging of the differentiated cells of brain or skeletal muscle. In human liver, cholangiocytes and hepatocytes show no age-related telomere shortening. Another study found little evidence that, in humans, telomere length is a significant biomarker of normal aging with respect to important cognitive and physical abilities. Some experiments have raised questions on whether telomerase can be used as an anti-aging therapy, namely, the fact that mice with elevated levels of telomerase have higher cancer incidence and hence do not live longer. On the other hand, one study showed that activating telomerase in cancer-resistant mice by overexpressing its catalytic subunit extended lifespan. A study found that long-lived subjects inherited a hyperactive version of telomerase. A telomerase activator TA-65 is commercially available and is claimed to delay aging and to provide relief from certain disease conditions. This formulation contains a molecule called cycloastragenol derived from a legume Astragalus membranaceus. Several other compounds have been found to increase telomerase activity: Centella asiatica extract 8.8-fold, oleanolic acid 5.9-fold, astragalus extract 4.3-fold, TA-65 2.2-fold, and maslinic acid 2-fold.
1936: Danish seismologist and geophysicist Inge Lehmann discovered that the Earth has a solid inner core distinct from its molten outer core. 1937: Canadian forensic pathologist Frances Gertrude McGill assisted the Royal Canadian Mounted Police in establishing their first forensic detection laboratory. 1937: Suzanne Comhaire-Sylvain became the first female Haitian anthropologist and the first Haitian person to complete a PhD, receiving her doctoral degree from the University of Paris. 1937: Marietta Blau and her student Hertha Wambacher, both Austrian physicists, received the Lieben Prize of the Austrian Academy of Sciences for their work on cosmic ray observations using the technique of nuclear emulsions. 1938: Nigerian physician Elizabeth Abimbola Awoliyi became the first woman to be licensed to practise medicine in Nigeria after graduating from Trinity College Dublin and the first West African female medical officer with a license of the Royal Surgeon (Dublin). 1938: Canadian geologist Alice Wilson became the first woman appointed as Fellow to the Royal Society of Canada. 1938: South African naturalist Marjorie Courtenay-Latimer discovered a living coelacanth fish caught near the Chalumna river. The species had been believed to be extinct for over 60 million years. It was named latimeria chalumnae in her honour.
9 February – Donald Cameron, a Conservative list MSP for the Highlands and Islands, announces he is standing down from the Scottish Parliament to take up a seat in the House of Lords and a junior ministerial post in the Scottish Office. 10 February – Police Scotland are investigating 22 deaths that occurred at the Fullarton Care Home in Irvine, North Ayrshire during the COVID-19 pandemic. The home was one of the worst affected during the early days of the pandemic. 11 February – Canadian woman Claire Leveque, aged 24, dies following a disturbance in Sandness, Shetland. Aren Pearson is subsequently charged with her murder. 12 February – Actor and writer Simon Fanshawe is named the new Rector of the University of Edinburgh, succeeding Debora Kayembe. A man is arrested and charged over several acts of vandalism in Glasgow, including graffiti relating to the Gaza conflict daubed on the city's cenotaph. 13 February – Former NHS worker Tracy Menhinick, who gave a young boy "industrial amounts" of the laxative lactulose, is found guilty of poisoning the child following a 19-day trial at the High Court in Aberdeen. 14 February – Jordan Mitchell, who spoke about his desire to commit mass murder in Falkirk during a hospital visit, and who said he had killed animals, is given an Order for Lifelong Restriction by the Court of Criminal Appeal. 15 February – Glasgow City Council and North Lanarkshire Council vote to freeze council tax for the 2024–25 financial year.
== Medical uses == Ciprofol is used for the intravenous induction of general anesthesia. Studies published in 2022 and 2023 found it was efficacious as a general anesthetic in people undergoing gynecological surgery and kidney transplantation, as well as for endoscopic procedures such as bronchoscopy, esophagogastroduodenoscopy and colonoscopy. Ciprofol has also been used for sedation of critically ill people undergoing mechanical ventilation in the intensive care unit, as well as for the treatment of agitation and delirium in that patient population. When combined with mild therapeutic hypothermia, ciprofol may also be useful as a cerebral protective agent in the setting of cerebral ischemia-reperfusion injury.
== Methodologies == Before testing samples, the tamper-evident seal is checked for integrity. If it appears to have been tampered with or damaged, the laboratory rejects the sample and does not test it. Next, the sample must be made testable. Urine and oral fluid can be used "as is" for some tests, but other tests require the drugs to be extracted from urine. Strands of hair, patches, and blood must be prepared before testing. Hair is washed in order to eliminate second-hand sources of drugs on the surface of the hair, then the keratin is broken down using enzymes. Blood plasma may need to be separated by centrifuge from blood cells prior to testing. Sweat patches are opened and the sweat collection component is removed and soaked in a solvent to dissolve any drugs present. Laboratory-based drug testing is done in two steps. The first step is the screening test, which is an immunoassay based test applied to all samples. The second step, known as the confirmation test, is usually undertaken by a laboratory using highly specific chromatographic techniques and only applied to samples that test positive during the screening test. Screening tests are usually done by immunoassay (EMIT, ELISA, and RIA are the most common). A "dipstick" drug testing method which could provide screening test capabilities to field investigators has been developed at the University of Illinois. After a suspected positive sample is detected during screening, the sample is tested using a confirmation test. Samples that are negative on the screening test are discarded and reported as negative.
Sources: en.wikipedia.org
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.
It was investigated in clinical trials for obesity, but it did not receive approval for that use in major markets. Results were generally modest or mixed, and it remains an experimental compound.
WADA lists it as a prohibited peptide hormone. Its use can be detected by laboratory methods, and athletes are subject to sanctions if it is found in samples.
It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, commonly referred to as hGH fragment 176-191. It has been investigated for effects on fat metabolism, but it is not an approved medication in most jurisdictions.